Gene · 644079
Papers2,404
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,404
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aluminum and ABC transporter activity. | Environ Toxicol Pharmacol | 2024 | 38648870 | PubTator, text mining | PubMed |
| One-step synthesis of diaryloxadiazoles as potent inhibitors of BCRP. | Future Med Chem | 2024 | 38573062 | PubTator, text mining | PubMed |
| Clinical analysis of 82 cases of acute promyelocytic leukemia with PML-RARα short isoform in children and adults. | Front Oncol | 2024 | 38450185 | PubTator, text mining | PubMed |
The Role of CYPs and Transporters in the Biotransformation and Transport of the Anti-hepatitis C Antiviral Agents Asunaprevir, Daclatasvir, and Beclabuvir: Impact of Liver Disease, Race and Drug-drug Interactions on Safety and Efficacy. | Curr Drug Metab | 2024 | 38441017 | PubTator, text mining | PubMed |
| Increased expression of ATP-binding cassette transporters in enfortumab vedotin-resistant urothelial cancer. | IJU Case Rep | 2024 | 38440718 | PubTator, text mining | PubMed |
| Functional intestinal monolayers from organoids derived from human iPS cells for drug discovery research. | Stem Cell Res Ther | 2024 | 38424603 | PubTator, text mining | PubMed |
| Recent Advances in Hepatic Metabolic Regulation by the Nuclear Factor Rev-erbɑ. | Curr Drug Metab | 2024 | 38409696 | PubTator, text mining | PubMed |
| Drug-resistant profiles of extracellular vesicles predict therapeutic response in TNBC patients receiving neoadjuvant chemotherapy. | BMC Cancer | 2024 | 38326737 | PubTator, text mining | PubMed |
| Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the Blood-Brain Barrier: The Discovery of AZD1390. | J Med Chem | 2024 | 38306388 | PubTator, text mining | PubMed |
| Acute promyelocytic leukemia with PML/RARA (bcr1, bcr2 and bcr3) transcripts in a pediatric patient. | Oncol Lett | 2024 | 38304177 | PubTator, text mining | PubMed |
| Evaluation of the drug-drug interaction potential of brigatinib using a physiologically-based pharmacokinetic modeling approach. | CPT Pharmacometrics Syst Pharmacol | 2024 | 38288787 | PubTator, text mining | PubMed |
| Editorial: Transporters: a hitchhiker's guide to physiology, toxicology, and pharmacology-TransportDays 2022. | Front Pharmacol | 2024 | 38288437 | PubTator, text mining | PubMed |
| Transplacental transport of per- and polyfluoroalkyl substances (PFAS): Mechanism exploration via BeWo cell monolayer model. | J Hazard Mater | 2024 | 38278074 | PubTator, text mining | PubMed |
| The Kidney-Gut Axis as a Novel Target for Nutritional Intervention to Counteract Chronic Kidney Disease Progression. | Metabolites | 2024 | 38276313 | PubTator, text mining | PubMed |
| Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment. | Pharmaceuticals (Basel) | 2024 | 38276008 | PubTator, text mining | PubMed |
| Atogepant: Mechanism of action, clinical and translational science. | Clin Transl Sci | 2024 | 38266063 | PubTator, text mining | PubMed |
| Human intestinal organoid-derived PDGFRα + mesenchymal stroma enables proliferation and maintenance of LGR4 + epithelial stem cells. | Stem Cell Res Ther | 2024 | 38229108 | PubTator, text mining | PubMed |
| Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells. | Cancer Chemother Pharmacol | 2024 | 38226983 | PubTator, text mining | PubMed |
| Overview of processed excipients in ocular drug delivery: Opportunities so far and bottlenecks. | Heliyon | 2024 | 38226207 | PubTator, text mining | PubMed |
| RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells. | Neoplasia | 2024 | 38219710 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/644079/papers?page=8